Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.135 USD | +4.13% |
|
-3.81% | +7.08% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.08% | 6.3Cr | |
+20.20% | 13TCr | |
+24.51% | 12TCr | |
+25.44% | 2.77TCr | |
-18.02% | 2.03TCr | |
-15.17% | 1.68TCr | |
-15.15% | 1.56TCr | |
+12.37% | 1.48TCr | |
-47.10% | 1.46TCr | |
+56.10% | 1.44TCr |
- Stock Market
- Equities
- SLS Stock
- News SELLAS Life Sciences Group, Inc.
- Sellas Life Sciences' Potential Leukemia Treatment Receives Second Rare Pediatric Disease Designation